| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH)
AMPH Technical Analysis
5
| As on 9th Jun 2023 AMPH STOCK Price closed @ 45.67 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 31.35 & Strong Buy for SHORT-TERM with Stoploss of 25.50 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AMPHSTOCK Price
| Open | 45.98 | Change | Price | % |
| High | 46.35 | 1 Day | -0.22 | -0.48 |
| Low | 45.55 | 1 Week | 1.30 | 2.93 |
| Close | 45.67 | 1 Month | 9.29 | 25.54 |
| Volume | 310300 | 1 Year | 23.48 | 105.81 |
| 52 Week High 46.70 | 52 Week Low 22.19 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AMPH Daily Charts |
AMPH Intraday Charts |
Whats New @ Bazaartrend |
AMPH Free Analysis |
|
|
AMPH Important Levels Intraday
| RESISTANCE | 47.21 |
| RESISTANCE | 46.72 |
| RESISTANCE | 46.41 |
| RESISTANCE | 46.11 |
| SUPPORT | 45.23 |
| SUPPORT | 44.93 |
| SUPPORT | 44.62 |
| SUPPORT | 44.13 |
AMPH Forecast April 2024
| 4th UP Forecast | 55.75 |
| 3rd UP Forecast | 52.52 |
| 2nd UP Forecast | 50.52 |
| 1st UP Forecast | 48.52 |
| 1st DOWN Forecast | 42.82 |
| 2nd DOWN Forecast | 40.82 |
| 3rd DOWN Forecast | 38.82 |
| 4th DOWN Forecast | 35.59 |
AMPH Weekly Forecast
| 4th UP Forecast | 48.31 |
| 3rd UP Forecast | 47.46 |
| 2nd UP Forecast | 46.94 |
| 1st UP Forecast | 46.42 |
| 1st DOWN Forecast | 44.92 |
| 2nd DOWN Forecast | 44.40 |
| 3rd DOWN Forecast | 43.88 |
| 4th DOWN Forecast | 43.03 |
AMPH Forecast2024
| 4th UP Forecast | 93.67 |
| 3rd UP Forecast | 78.28 |
| 2nd UP Forecast | 68.76 |
| 1st UP Forecast | 59.25 |
| 1st DOWN Forecast | 32.09 |
| 2nd DOWN Forecast | 22.58 |
| 3rd DOWN Forecast | 13.06 |
| 4th DOWN Forecast | -2.33 |
Amphastar Pharmaceuticals Inc ( NASDAQ USA Symbol : AMPH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AMPH Business Profile
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Address: 11570 6th Street, Rancho Cucamonga, CA, United States, 91730
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service